CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models.

Zhang B, Guan M, Xie XT, Zou JH, Cheng K, Zhao YD, Liu B, Fan JX, Xu QR

Open source

DOI
10.1038/s41467-026-76823-7
Published
2026 Aug 21
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-76823-7,
  title = {CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models.},
  author = {Zhang B and Guan M and Xie XT and Zou JH and Cheng K and Zhao YD and Liu B and Fan JX and Xu QR},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-76823-7},
  url = {https://doi.org/10.1038/s41467-026-76823-7}
}

RIS

TY  - JOUR
TI  - CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models.
AU  - Zhang B
AU  - Guan M
AU  - Xie XT
AU  - Zou JH
AU  - Cheng K
AU  - Zhao YD
AU  - Liu B
AU  - Fan JX
AU  - Xu QR
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-76823-7
UR  - https://doi.org/10.1038/s41467-026-76823-7
ER  - 

APA

B, Z., M, G., XT, X., JH, Z., K, C., YD, Z., B, L., JX, F., & QR, X. (2026). CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models.. Nature communications. https://doi.org/10.1038/s41467-026-76823-7

Source records